| xHyp3D vs Clive | 95–181 | 34.42% |
| xHyp3D vs Jin | 79–105 | 42.93% |
| xHyp3D vs Reina | 89–85 | 51.15% |
| xHyp3D vs Kazuya | 73–80 | 47.71% |
| xHyp3D vs Hwoarang | 51–85 | 37.50% |
| xHyp3D vs Law | 49–82 | 37.40% |
| xHyp3D vs Heihachi | 55–74 | 42.64% |
| xHyp3D vs Steve | 39–73 | 34.82% |
| xHyp3D vs King | 46–62 | 42.59% |
| xHyp3D vs Bryan | 48–56 | 46.15% |
| xHyp3D vs Dragunov | 34–60 | 36.17% |
| xHyp3D vs Nina | 42–45 | 48.28% |
| xHyp3D vs Devil Jin | 35–50 | 41.18% |
| xHyp3D vs Jun | 37–48 | 43.53% |
| xHyp3D vs Lili | 28–49 | 36.36% |
| xHyp3D vs Azucena | 29–48 | 37.66% |
| xHyp3D vs Lee | 28–46 | 37.84% |
| xHyp3D vs Victor | 26–44 | 37.14% |
| xHyp3D vs Paul | 31–38 | 44.93% |
| xHyp3D vs Alisa | 28–31 | 47.46% |
| xHyp3D vs Yoshimitsu | 18–36 | 33.33% |
| xHyp3D vs Xiaoyu | 16–37 | 30.19% |
| xHyp3D vs Eddy | 21–26 | 44.68% |
| xHyp3D vs Asuka | 17–28 | 37.78% |
| xHyp3D vs Lidia | 22–22 | 50.00% |
| xHyp3D vs Lars | 7–35 | 16.67% |
| xHyp3D vs Raven | 22–18 | 55.00% |
| xHyp3D vs Leroy | 17–20 | 45.95% |
| xHyp3D vs Feng | 11–25 | 30.56% |
| xHyp3D vs Jack-8 | 15–19 | 44.12% |
| xHyp3D vs Leo | 13–21 | 38.24% |
| xHyp3D vs Kuma | 14–20 | 41.18% |
| xHyp3D vs Shaheen | 8–16 | 33.33% |
| xHyp3D vs Zafina | 12–11 | 52.17% |
| xHyp3D vs Panda | 10–6 | 62.50% |
| xHyp3D vs Claudio | 4–8 | 33.33% |
| xHyp3D vs Anna | 0–2 | 0.00% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.